Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A concise review on the therapeutics of obesity
The half-life of tirzepatide is approximately five days, meaning weekly injections maintain therapeutic plasma levels throughout the dosing cycle
Macromolecule Content Total Structure Weight: 156.9 kDa Atom Count: 8,937 Modeled Residue Count: 1,157 Deposited Residue Count: 1,386 Unique protein chains: 6 Experimental Data Method: ELECTRON MICROSCOPY Resolution: 2.84 Aggregation State: PARTICLE Reconstruction Method: SINGLE PARTICLE EM Software: Deposition Data Released Date: 2024-08-07 Deposition Author(s): Li, W.Z., Zhou, Q.T., Cong, Z.T., Yuan, Q.N., Li, W.X., Zhao, F.H., Xu, H.E., Zhao, L.H., Yang, D.H., Wang, M.W
Obesity can increase insulin resistance, disrupt hormone levels, worsen menstrual irregularities, and reduce the likelihood of regular ovulation
When gastric emptying slows, glucose enters the bloodstream more gradually after meals
Available at: Wilding JPH, Batterham RL, Davies M, et al
US$ 25.49
US$ 22.63
US$ 26.68
